Back
Krystal Biotech, Inc. (KRYS)
BiotechnologyKRYS · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$331.59
+1.27%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$6.84
ROE
19.9%
Gross margin
94.2%
Debt/Equity
0.71x
Revenue growth
31.9%
Krystal Biotech, Inc. — company intelligence
Earnings surprises
Q2 2026$1.79 vs $1.69 est+6.0%
Q1 2026$1.83 vs $1.45 est+26.3%
Q4 2025$1.70 vs $1.44 est+18.3%
Q3 2025$2.66 vs $1.11 est+140.2%
Analyst consensus · 19 analysts
17 Buy2 Hold0 Sell
Updated Oct 7, 2026
Insider activity · 90 days
12 buys34 sellsnet -65,052 shares
Gangolli Julian SBuy 471 · Sep 14, 2026
Gangolli Julian SBuy 1,187 · Sep 14, 2026
JANNEY DANIELBuy 471 · Sep 14, 2026
Recent SEC filings
4 — Insider transaction reportSep 16, 2026
4 — Insider transaction reportSep 16, 2026
4 — Insider transaction reportSep 16, 2026
Latest news
Why Krystal Biotech (KRYS) Is Drawing Fresh Attention — Yahoo · 2d ago
Krystal Biotech (KRYS) Stock Looks Overvalued After A 7x Run — Yahoo · 2d ago
$1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today — Benzinga · 4d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.